ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,266Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 2035

$1.74M Total Retail Price of All Prescriptions

Rank: 11 out of 2035

803 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 803 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 803 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 23,018 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
FUROSEMIDE 954 813 1 7
NAMENDA 826 770 2 37
AMLODIPINE BESYLATE 780 683 3 6
LEVOTHYROXINE SODIUM 731 557 4 4
DONEPEZIL HCL 703 656 5 24
TRAZODONE HCL 702 570 6 50
HYDROCODONE-ACETAMINOPHEN 655 499 S3 7 2
LISINOPRIL 653 542 8 3
SIMVASTATIN 650 543 9 1
GABAPENTIN 634 413 10 14
TRAMADOL HCL 627 502 11 19
WARFARIN SODIUM 626 374 12 11
SERTRALINE HCL 623 474 13 23
OMEPRAZOLE 605 470 14 5
POLYETHYLENE GLYCOL 3350 591 541 15 48
CITALOPRAM HBR 555 491 16 20
METOPROLOL TARTRATE 529 384 17 8
FENTANYL 494 335 S2 18 53
DIVALPROEX SODIUM 487 386 19 75
RISPERIDONE 418 246 20 68
CARVEDILOL 375 327 21 22
MIRTAZAPINE 360 343 22 46
PANTOPRAZOLE SODIUM 323 196 23 42
LANTUS SOLOSTAR 319 275 24 66
POTASSIUM CHLORIDE 305 246 25 18
TAMSULOSIN HCL 286 240 26 25
CYMBALTA 283 208 27 59
NYSTOP 269 201 28 150
ATORVASTATIN CALCIUM 258 212 29 13
NOVOLOG FLEXPEN 257 187 30 133
HYDRALAZINE HCL 239 209 31 45
METOPROLOL SUCCINATE 228 189 32 16
IPRATROPIUM-ALBUTEROL 227 189 33 146
PROMETHAZINE HCL 224 122 R 34 106
BACLOFEN 197 41 35 112
HYDROCORTISONE 192 138 36 156
QUETIAPINE FUMARATE 192 175 36 70
ADVAIR DISKUS 189 136 38 38
LIDOCAINE HCL 184 156 39 205
CLONIDINE HCL 183 155 40 61
LEVETIRACETAM 183 112 40 87
CIPROFLOXACIN HCL 182 147 42 63
LEVOFLOXACIN 178 115 43 99
SPIRIVA 176 154 44 44
LANTUS 174 143 45 40
ALBUTEROL SULFATE 171 106 46 90
PRAVASTATIN SODIUM 170 136 47 17
KLOR-CON M20 170 139 47 73
LEVEMIR FLEXPEN 166 102 49 204
DOXYCYCLINE HYCLATE 165 132 50 129
PREDNISONE 165 114 50 36
FLUTICASONE PROPIONATE 162 141 52 29
SODIUM CHLORIDE 161 96 53 216
CARBIDOPA-LEVODOPA 161 147 53 94
ALLOPURINOL 158 137 55 34
NYSTATIN 155 110 56 103
FINASTERIDE 153 140 57 105
OXYBUTYNIN CHLORIDE ER 149 117 58 117
CEPHALEXIN 142 95 59 91
PAROXETINE HCL 139 126 60 69
CLOPIDOGREL 128 109 61 30
OLANZAPINE 122 53 62 121
SULFAMETHOXAZOLE-TRIMETHOPRIM 119 86 63 110
IPRATROPIUM BROMIDE 116 69 64 148
MORPHINE SULFATE ER 115 109 S2 65 86
ISOSORBIDE MONONITRATE ER 106 89 66 32
PEN NEEDLE 105 79 67 100
ALENDRONATE SODIUM 105 89 67 27
METFORMIN HCL 103 87 69 9
PRADAXA 103 97 69 242
FENOFIBRATE 102 82 71 82
NOVOLOG 102 74 71 95
VENLAFAXINE HCL ER 101 64 73 130
DILTIAZEM 24HR CD 95 87 74 122
CHOLESTYRAMINE 93 75 75 298
MORPHINE SULFATE 90 74 S2 76 183
TOBRAMYCIN SULFATE 90 54 10 76 407
ONDANSETRON HCL 89 41 78 342
ROPINIROLE HCL 88 65 79 113
HYDROMORPHONE HCL 87 35 S2 80 159
CARBAMAZEPINE 87 24 80 228
HEPARIN SODIUM 85 48 82 227
LAMOTRIGINE 85 37 82 203
SEROQUEL 85 76 82 153
TRAVATAN Z 82 80 85 199
ATENOLOL 82 66 85 10
OXYCODONE HCL 81 22 S2 87 62
HYDROCHLOROTHIAZIDE 81 70 87 12
ESCITALOPRAM OXALATE 79 60 89 77
CEFTRIAXONE 77 48 90 217
SPIRONOLACTONE 77 62 90 65
FAMOTIDINE 77 59 90 71
LEVEMIR 73 44 93 236
CLONIDINE 73 71 93 277
METOLAZONE 67 47 95 162
PLAVIX 66 61 96 49
ZOLPIDEM TARTRATE 64 34 97 21
AZITHROMYCIN 63 49 98 39
VENTOLIN HFA 63 44 98 80
ARICEPT 62 62 100 433
BUPROPION HCL SR 62 45 100 202
BUPROPION HCL 62 32 100 302
AMOX TR-POTASSIUM CLAVULANATE 62 48 100 168
TERAZOSIN HCL 62 48 100 149
CYCLOBENZAPRINE HCL 60 43 R 105 64
DIVALPROEX SODIUM ER 60 49 105 226
CHLORHEXIDINE GLUCONATE 59 41 107 224
LANSOPRAZOLE 59 36 107 118
AMIODARONE HCL 58 52 109 171
TRANSDERM-SCOP 57 19 110 271
MEGESTROL ACETATE 55 45 R 111 175
LOPERAMIDE 54 45 112 270
AMOXICILLIN 54 39 112 116
IBUPROFEN 52 39 114 43
PHENYTOIN SODIUM EXTENDED 51 39 115 132
HYDROXYZINE HCL 51 17 R 115 208
EXELON 51 51 115 151
SENSIPAR 50 40 118 310
BENZTROPINE MESYLATE 50 12 R 118 223
RENVELA 50 36 118 245
LACTULOSE 50 13 118 96
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 21, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.